Synthesis and SAR studies with a first in class series of non-peptide motilin receptor antagonists.

被引：0

作者：

Xiang, MA ^{[1
]}

Ryhczynski, P ^{[1
]}

Chen, RHK ^{[1
]}

Beavers, MP ^{[1
]}

Combs, DW ^{[1
]}

Gunnet, JI ^{[1
]}

Hageman, W ^{[1
]}

Moore, JB ^{[1
]}

Zhou, LB ^{[1
]}

Urbanski, M ^{[1
]}

Demarest, KT ^{[1
]}

机构：

[1] Johnson & Johnson Pharmaceut Res & Dev LLC, Raritan, NJ 08869 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2004年 / 228卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

033-MEDI

引用

页码：U912 / U912

页数：1

共 50 条

[31] Peptide and non-peptide bradykinin receptor antagonists: Role in allergic airway disease
Abraham, WM
Scuri, M
Farmer, SG
EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 533 (1-3) : 215 - 221
[32] A novel class of orally active non-peptide bradykinin B2 receptor antagonists.: 4.: Discovery of novel frameworks mimicking the active conformation
Abe, Y
Kayakiri, H
Satoh, S
Inoue, T
Sawada, Y
Inamura, N
Asano, M
Aramori, I
Hatori, C
Sawai, H
Oku, T
Tanaka, H
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (23) : 4587 - 4598
[33] Design and synthesis of a series of non-peptide high-affinity human corticotropin-releasing factor(1) receptor antagonists
Chen, C
Dagnino, R
DeSouza, EB
Grigoriadis, DE
Huang, CQ
Kim, KI
Liu, ZY
Moran, T
Webb, TR
Whitten, JP
Xie, YF
McCarthy, JR
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (22) : 4358 - 4360
[34] Design, synthesis, and SAR studies of 2-dialkylamino-4 arylpyrimidines as potent CRF receptor antagonists.
Chen, C
Huang, CQ
Whitten, JP
Xie, MY
Grigoriadas, DE
Danino, R
Liu, Z
Ramphal, J
De Souza, EB
Webb, T
McCarthy, JR
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U948 - U948
[35] Design and pharmacological evaluation of a series of non-peptide endothelin ETA selective and ETA/ETB receptor antagonists
Doherty, A
Patt, W
Reisdorph, B
Repine, J
Walker, D
Flynn, M
Welch, K
Reynolds, E
Haleen, S
MEDICINAL CHEMISTRY: TODAY AND TOMORROW, 1997, : 255 - 261
[36] Synthesis and SAR of a series of N-isoxazolyl biphenylsulfonamides as potent dual angiotensin II and endothelin A receptor antagonists.
Gu, ZX
Fadnis, L
Tellew, JE
Kane, B
Cornelius, L
Baska, RA
Beyer, S
Monshizadegan, H
Valentine, M
Chong, S
Morrison, RA
Carlson, K
Ewing, WR
Kowala, M
Macor, JE
Murugesan, N
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U60 - U60
[37] An update on non-peptide angiotensin receptor antagonists and related RAAS modulators
Aulakh, G. K.
Sodhi, R. K.
Singh, M.
LIFE SCIENCES, 2007, 81 (08) : 615 - 639
[38] A novel template for non-peptide CCR5 receptor antagonists
不详
EXPERT OPINION ON THERAPEUTIC PATENTS, 2001, 11 (04) : 697 - 700
[39] Superimposition of potent non-peptide AT(1) receptor antagonists with angiotensin II
Theodoropoulou, E
Mavromoustakos, T
Panagiotopoulos, D
Matsoukas, JM
Smith, J
LETTERS IN PEPTIDE SCIENCE, 1996, 3 (04): : 209 - 216
[40] Discovery of novel non-peptide CCR1 receptor antagonists
Ng, HP
May, K
Bauman, JG
Ghannam, A
Islam, I
Liang, M
Horuk, R
Hesselgesser, J
Snider, RM
Perez, HD
Morrissey, MM
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (22) : 4680 - 4694

← 1 2 3 4 5 →